4:02 pm Celator Pharma announces start of clinical study of CPX-351 in relapsed/refractory higher risk myelodysplastic syndrome and acute myeloid leukemia patients
View todays social media effects on CPXX
View the latest stocks trending across Twitter. Click to view dashboard
See who Celator is hiring next, click here to view
